• LABline
  • Magazine Archive
  • Webinars
  • Whitepapers
  • eBooks
  • Videos
  • Subscribe
    • ID 352854279 © Juan Moyano | Dreamstime.com
    dreamstime_xxl_352854279
    Cancer

    At-home prostate cancer test

    Erin Brady
    Feb. 4, 2025
    New study published in The Journal of Urology.
    ID 196738515 © Norbert Dr. Lange | Dreamstime.com
    dreamstime_xxl_196738515
    Courtesy of NCI, NIH
    From 1975 to 2020, prevention and screening efforts averted 4.75 million deaths from five cancer types: breast, cervical colorectal, lung prostate. NCI.
    Cancer

    In five cancer types, prevention and screening have been major contributors to saving lives

    LABline
    Dec. 6, 2024
    NIH modeling study looked at the individual and combined impacts of cancer prevention, screening, and treatment.
    ID 151197268 © Serezniy | Dreamstime.com
    dreamstime_xxl_151197268
    Cancer

    More cancers are being treated with personalized therapies before surgery

    LABline
    Dec. 4, 2024
    New treatment options and early detection are helping improve cancer care, according to the first-ever annual report from the National Cancer Database of the American College ...
    ID 345596745 © Anatolii Savitskii | Dreamstime.com
    dreamstime_xxl_345596745
    Cancer

    Enzyme identified as new therapeutic target for “cold” tumors

    LABline
    Dec. 4, 2024
    Drugs that suppress UBA1 could make immune checkpoint blocking immunotherapy effective for patients with prostate cancer and other “cold” tumors.
    ID 270571968 © Luchschen | Dreamstime.com
    dreamstime_xxl_270571968
    Cancer

    Diabetes drug appears to fight lung cancer — but only in overweight or obese patients

    LABline
    Nov. 26, 2024
    Retrospective study led by Roswell Park’s Dr. Sai Yendamuri provides long-sought evidence.
    ID 204969634 © Sulit Photos | Dreamstime.com
    dreamstime_xxl_204969634
    Cancer

    FDA grants accelerated approval to zanidatamab-hrii

    LABline
    Nov. 25, 2024
    Approval for previously treated unresectable or metastatic HER2-positive biliary tract cancer.
    ID 322970657 © Leo Rohmann | Dreamstime.com
    dreamstime_xxl_322970657
    Cancer

    Owkin and Proscia expand access to AI pre-screening for colorectal cancer patients

    LABline
    Nov. 20, 2024
    Partnership will assist pathologists in the pre-screening of patients with microsatellite stable (MSS) / proficient mismatch repair (pMMR) in colorectal tumors.
    ID 340556497 © Svitlana Kuchina | Dreamstime.com
    dreamstime_xxl_340556497
    Cancer

    Drug combination prompts immune response in some resistant pancreatic cancers

    LABline
    Nov. 15, 2024
    New drug strategy studied by Johns Hopkins researchers.
    ID 76886763 © Jiri Hera | Dreamstime.com
    dreamstime_xxl_76886763
    Cancer

    Vaccine shows promise against aggressive breast cancer

    LABline
    Nov. 14, 2024
    Clinical trial targeted recurrence of hard-to-treat triple-negative breast cancer.
    ID 343308523 © Yuri Arcurs | Dreamstime.com
    dreamstime_xxl_343308523
    Cancer

    Combination approach shows promise for treating rare, aggressive cancers

    LABline
    Nov. 13, 2024
    UCLA research finds that combining immunotherapy with chemotherapy is safe and effective for people with advanced small cell cancers in the bladder and prostate.

    Cancer

    ID 146642679 © Monthira Yodtiwong | Dreamstime.com
    dreamstime_xxl_146642679
    ID 51651973 © Wavebreakmedia Ltd | Dreamstime.com
    dreamstime_xxl_51651973
    ID 320261498 © Justlight | Dreamstime.com
    dreamstime_xxl_320261498
    ID 186156891 © Noipornpan | Dreamstime.com
    dreamstime_xxl_186156891
    ID 322613595 © Oksanabratanova | Dreamstime.com
    dreamstime_xxl_322613595
    ID 330704328 © Everydayplus | Dreamstime.com
    dreamstime_xxl_330704328
    Courtesy of the NCI, NIH
    The Human Tumor Atlas Network seeks to understand the molecular features of tumors and their microenvironments. NCI.